questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines mitochondriales
Protéines de transport de la membrane mitochondriale
Protéines de découplage mitochondrial
Protéines de découplage mitochondrial : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de découplage mitochondrial : Questions médicales les plus fréquentes",
"headline": "Protéines de découplage mitochondrial : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de découplage mitochondrial : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-25",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de découplage mitochondrial"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de transport de la membrane mitochondriale",
"url": "https://questionsmedicales.fr/mesh/D033681",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de transport de la membrane mitochondriale",
"code": {
"@type": "MedicalCode",
"code": "D033681",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine-1 de découplage",
"alternateName": "Uncoupling Protein 1",
"url": "https://questionsmedicales.fr/mesh/D000071256",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-1 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-2 de découplage",
"alternateName": "Uncoupling Protein 2",
"url": "https://questionsmedicales.fr/mesh/D000071246",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-2 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 de découplage",
"alternateName": "Uncoupling Protein 3",
"url": "https://questionsmedicales.fr/mesh/D000071247",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines de découplage mitochondrial",
"alternateName": "Mitochondrial Uncoupling Proteins",
"code": {
"@type": "MedicalCode",
"code": "D000071245",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Colin J Barnstable",
"url": "https://questionsmedicales.fr/author/Colin%20J%20Barnstable",
"affiliation": {
"@type": "Organization",
"name": "Department of Neural and Behavioral Sciences, The Pennsylvania State University, Hershey, PA, 17033, USA. Electronic address: cbarnstable@pennstatehealth.psu.edu."
}
},
{
"@type": "Person",
"name": "Elena A Kotova",
"url": "https://questionsmedicales.fr/author/Elena%20A%20Kotova",
"affiliation": {
"@type": "Organization",
"name": "Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia."
}
},
{
"@type": "Person",
"name": "Yuri N Antonenko",
"url": "https://questionsmedicales.fr/author/Yuri%20N%20Antonenko",
"affiliation": {
"@type": "Organization",
"name": "Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. antonen@belozersky.msu.ru."
}
},
{
"@type": "Person",
"name": "Ljudmila S Khailova",
"url": "https://questionsmedicales.fr/author/Ljudmila%20S%20Khailova",
"affiliation": {
"@type": "Organization",
"name": "Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia."
}
},
{
"@type": "Person",
"name": "Elena E Pohl",
"url": "https://questionsmedicales.fr/author/Elena%20E%20Pohl",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences, Institute of Physiology, Pathophysiology and Biophysics, University of Veterinary Medicine, 1210 Vienna, Austria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Protein nanopore reveals the renin-angiotensin system crosstalk with single-amino-acid resolution.",
"datePublished": "2023-02-20",
"url": "https://questionsmedicales.fr/article/36805037",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41557-023-01139-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset.",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36395543",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.10.019"
}
},
{
"@type": "ScholarlyArticle",
"name": "What do we know about the renin angiotensin system and inflammatory bowel disease?",
"datePublished": "2022-12-22",
"url": "https://questionsmedicales.fr/article/36484415",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14728222.2022.2157261"
}
},
{
"@type": "ScholarlyArticle",
"name": "Renin-Angiotensin-Aldosterone System in Women Using Combined Oral Contraceptive: A Systematic Review.",
"datePublished": "2022-06-20",
"url": "https://questionsmedicales.fr/article/35724684",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0042-1745790"
}
},
{
"@type": "ScholarlyArticle",
"name": "Use of renin angiotensin aldosterone system inhibitors in children with lupus and time to glucocorticoid discontinuation.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35618096",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.kint.2022.04.023"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines mitochondriales",
"item": "https://questionsmedicales.fr/mesh/D024101"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de transport de la membrane mitochondriale",
"item": "https://questionsmedicales.fr/mesh/D033681"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines de découplage mitochondrial",
"item": "https://questionsmedicales.fr/mesh/D000071245"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de découplage mitochondrial - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de découplage mitochondrial",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines de découplage mitochondrial",
"description": "Comment diagnostiquer une dysfonction des UCP ?\nQuels tests sont utilisés pour évaluer les UCP ?\nLes biopsies musculaires sont-elles utiles ?\nQuels symptômes peuvent indiquer un problème d'UCP ?\nLes tests génétiques sont-ils fiables ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Renin-Angiotensin+System&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines de découplage mitochondrial",
"description": "Quels sont les symptômes d'une suractivité des UCP ?\nComment une sous-activité des UCP se manifeste-t-elle ?\nLes UCP affectent-ils la température corporelle ?\nY a-t-il des symptômes neurologiques associés ?\nLes UCP influencent-elles le métabolisme des lipides ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Renin-Angiotensin+System&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines de découplage mitochondrial",
"description": "Comment prévenir les dysfonctionnements des UCP ?\nLe stress oxydatif affecte-t-il les UCP ?\nLes antioxydants aident-ils à protéger les UCP ?\nL'alimentation influence-t-elle la santé mitochondriale ?\nLe tabagisme affecte-t-il les UCP ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Renin-Angiotensin+System&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines de découplage mitochondrial",
"description": "Quels traitements ciblent les UCP ?\nL'exercice physique aide-t-il à réguler les UCP ?\nLes suppléments nutritionnels sont-ils bénéfiques ?\nY a-t-il des traitements expérimentaux ?\nComment la diète influence-t-elle les UCP ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Renin-Angiotensin+System&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines de découplage mitochondrial",
"description": "Quelles complications peuvent survenir avec des UCP dysfonctionnelles ?\nLes UCP sont-elles liées à l'obésité ?\nLes maladies neurodégénératives sont-elles associées aux UCP ?\nLes UCP affectent-elles la santé cardiaque ?\nY a-t-il un lien entre UCP et diabète ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Renin-Angiotensin+System&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines de découplage mitochondrial",
"description": "Quels facteurs de risque influencent les UCP ?\nL'âge affecte-t-il la fonction des UCP ?\nLes maladies génétiques influencent-elles les UCP ?\nLe mode de vie sédentaire impacte-t-il les UCP ?\nLe stress psychologique influence-t-il les UCP ?",
"url": "https://questionsmedicales.fr/mesh/D000071245?mesh_terms=Renin-Angiotensin+System&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des UCP ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses biochimiques des mitochondries peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les UCP ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la mesure de la respiration mitochondriale et l'analyse des métabolites."
}
},
{
"@type": "Question",
"name": "Les biopsies musculaires sont-elles utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent d'évaluer la fonction mitochondriale et les niveaux d'UCP."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème d'UCP ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, intolérance à l'exercice et troubles métaboliques peuvent être des signes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils fiables ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations spécifiques liées aux UCP."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une suractivité des UCP ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivité peut entraîner une perte de poids et une intolérance au froid."
}
},
{
"@type": "Question",
"name": "Comment une sous-activité des UCP se manifeste-t-elle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut causer une prise de poids, une fatigue accrue et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les UCP affectent-ils la température corporelle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles jouent un rôle dans la thermogenèse et la régulation de la température."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs et des douleurs neuropathiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les UCP influencent-elles le métabolisme des lipides ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont impliquées dans la régulation du métabolisme lipidique et glucidique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dysfonctionnements des UCP ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain avec une alimentation équilibrée et de l'exercice régulier."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif affecte-t-il les UCP ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut altérer la fonction des UCP, donc le réduire est crucial."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à protéger les UCP ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent réduire les dommages mitochondriaux et soutenir les UCP."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé mitochondriale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments favorise la santé mitochondriale et les UCP."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il les UCP ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut nuire à la fonction mitochondriale et aux UCP."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les UCP ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les agonistes des UCP et des interventions diététiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à réguler les UCP ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice peut améliorer la fonction mitochondriale et l'activité des UCP."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels sont-ils bénéfiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antioxydants et des acides gras oméga-3 peuvent soutenir la fonction des UCP."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des modulateurs de l'UCP sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Comment la diète influence-t-elle les UCP ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diète riche en acides gras insaturés peut stimuler l'activité des UCP."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des UCP dysfonctionnelles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques, des maladies cardiovasculaires et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "Les UCP sont-elles liées à l'obésité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction des UCP peut contribuer à l'obésité et à la résistance à l'insuline."
}
},
{
"@type": "Question",
"name": "Les maladies neurodégénératives sont-elles associées aux UCP ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies des UCP peuvent être impliquées dans des maladies comme Alzheimer."
}
},
{
"@type": "Question",
"name": "Les UCP affectent-elles la santé cardiaque ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des UCP dysfonctionnelles peuvent augmenter le risque de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre UCP et diabète ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies des UCP peuvent influencer le métabolisme du glucose et le diabète."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les UCP ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'alimentation, le mode de vie sédentaire et le stress oxydatif sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge affecte-t-il la fonction des UCP ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut altérer la fonction mitochondriale et des UCP."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques influencent-elles les UCP ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations génétiques peuvent affecter la production et la fonction des UCP."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire impacte-t-il les UCP ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut réduire l'activité des UCP et la santé mitochondriale."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il les UCP ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction mitochondriale et des UCP."
}
}
]
}
]
}
The discovery of crosstalk effects on the renin-angiotensin system (RAS) is limited by the lack of approaches to quantitatively monitor, in real time, multiple components with subtle differences and s...
To explore the potential clinical effects of renin-angiotensin system blocker (RASB, angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs)) in patients from the ...
One hundred and seven untreated, newly diagnosed PD patients with hypertension, from the PPMI were included. We measured cognitive performance, biomarkers in CSF, and magnetic resonance imaging (MRI) ...
Treatment with ARBs but not ACEIs improved global cognitive function evaluated by MoCA score in PD patients with hypertension compared to other hypertensive medicines up to 5 years follow up. Specific...
These results show potential protective effect with ARBs in cognitive impairment of parkinson's disease with hypertension....
The renin-angiotensin system (RAS) is an important homeostatic pathway, with emerging evidence for the impact of its components on inflammation and fibrosis in gastrointestinal tissues. This review ai...
An extensive online literature review including Pubmed, Medline, and Google Scholar was undertaken. Discussion on the components of the RAS, localization, and physiological functions in the gastrointe...
RAS inhibition may have a role as anti-fibrotic adjunct therapy. Targeting the local gastrointestinal RAS with novel modes of delivery may be a target for future therapeutics for IBD, given the widesp...
To describe the effects of combined oral contraceptives (COC) on the renin-angiotensin-aldosterone system (RAAS)....
This is a systematic review according to the criteria of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), registered in PROSPERO under the ID: CRD42020200019. Searches were...
A total of 877 studies were selected and, of these, 10 articles met the eligibility criteria and were included in this review....
Data were combined through qualitative synthesis and included in a spreadsheet previously prepared by the authors....
The collected samples ranged from 18 to 137 participants, totaling 501 women aged between 18 and 49 years throughout all studies. The studies showed increased activity of plasma renin, plasma renin su...
The findings of this study suggest that the COC promotes greater activation of the RAAS. Supporting the idea that its use is related to an increased risk of cardiovascular events, including systemic a...
There is little data to inform use of renin angiotensin aldosterone system (RAAS) inhibitors in pediatric patients with systemic lupus erythematosus (SLE). Here, we sought to characterize RAAS inhibit...
Inhibition of Renin-Angiotensin-Aldosterone-System (RAAS) has been hypothesized to improve endothelial function and reduce plaque inflammation, however, their impact on the progression of coronary ath...
We performed a prospective, multinational study consisting of a registry of patients without history of CAD, who underwent serial CCTAs. Patients using RAAS inhibitors were propensity matched to RAAS ...
Of 1248 patients from the registry, 299 RAAS inhibitor taking patients were matched to 299 RAAS inhibitor naïve patients. Over a mean interval of 3.9 years, there was no significant difference in annu...
The use of RAAS inhibitors over a period of nearly 4 years did not significantly impact on total atherosclerotic plaque progression or various plaque components. However, interaction testing to assess...
To determine the association of prior use of renin-angiotensin-aldosterone system inhibitors (RAASIs) with mortality and outcomes in hospitalized patients with COVID-19....
Retrospective observational study....
Multicenter, international COVID-19 registry....
Adult hospitalized COVID-19 patients on antihypertensive agents (AHAs) prior to admission, admitted from March 31, 2020, to March 10, 2021....
None....
Data were compared between three groups: patients on RAASIs only, other AHAs only, and those on both medications. Multivariable logistic and linear regressions were performed after controlling for pre...
Among patients hospitalized for COVID-19 who were taking AHAs, prior use of a combination of RAASIs and other AHAs was associated with higher in-hospital mortality than the use of RAASIs alone. When c...
SARS-CoV-2 infection and its clinical manifestations (COVID-19) quickly evolved to a pandemic and a global public health emergency. The limited effectivity of available treatments aimed at reducing vi...
Human serum albumin (HSA) is an endogenous inhibitor of angiotensin I-converting enzyme (ACE) and, thus, plays a key role in the renin-angiotensin-aldosterone system (RAAS). However, little is known a...
Discontinuation of renin-angiotensin-aldosterone system inhibitor (RAASi) is common after hyperkalemia. We evaluated the risk of kidney and mortality outcomes associated with RAASi discontinuation amo...
We identified adult patients with CKD (eGFR <60 mL/min/1.73 m2) who experienced new-onset hyperkalemia (potassium ≥5.0 mEq/L) between 2016 and 2017 from Kaiser Permanente Southern California and fo...
Among 5,728 patients (mean age 76 years), 13.5% discontinued RAASi within 3 months after new-onset hyperkalemia. During the median 2 years of follow-up, 29.7% had the primary composite outcome (15.5% ...
RAASi discontinuation after hyperkalemia was associated with worsened mortality, which may underscore the benefits of continuing RAASi among patients with CKD....